NextCure Ownership | Who Owns NextCure?
NextCure Ownership Summary
NextCure is owned by 37.01% institutional investors, 2.14% insiders, and 60.85% retail investors. Sofinnova investments is the largest institutional shareholder, holding 9.38% of NXTC shares. Vanguard US Total Market Shares ETF is the top mutual fund, with 2.19% of its assets in NextCure shares.
NXTC Ownership Benchmark
Type | Name | % Inst | % Insiders | % Retail |
---|---|---|---|---|
Stock | NextCure | 37.01% | 2.14% | 60.85% |
Sector | Healthcare Stocks | 488.17% | 11.08% | -399.26% |
Industry | Biotech Stocks | 306.59% | 11.10% | -217.69% |
Institutional Shareholders
Top Institutional Shareholders by Total Shares
Holder | Shares | % Holding | Value |
---|---|---|---|
Sofinnova investments | 2.67M | 9.38% | $1.23M |
Affinity asset advisors | 2.30M | 8.08% | $1.06M |
Citigroup | 1.39M | 4.97% | $1.07M |
Vanguard group | 987.32K | 3.53% | $761.23K |
Blackrock | 761.18K | 2.73% | $1.21M |
Cable car capital | 615.88K | 2.20% | $474.84K |
Renaissance | 519.30K | 1.86% | $400.38K |
Acadian asset management | 488.44K | 1.71% | $223.00K |
Blackrock funding, inc. /de | 376.02K | 1.32% | $172.97K |
Cardiff park advisors | 262.00K | 0.92% | $120.52K |
Top Institutional Shareholders by % of Total Assets
Holder | Shares | % Assets | Value |
---|---|---|---|
Pfizer | 157.65K | 0.15% | $870.21K |
Affinity asset advisors | 2.30M | 0.14% | $1.06M |
Sofinnova investments | 2.67M | 0.08% | $1.23M |
Sio capital management | 131.30K | 0.02% | $60.40K |
Cable car capital | 615.88K | 0.02% | $474.84K |
Velan capital investment management lp | 25.00K | 0.02% | $19.27K |
Cardiff park advisors | 262.00K | 0.01% | $120.52K |
Adar1 capital management | 118.01K | 0.01% | $54.29K |
Armistice capital | 104.00K | 0.00% | $47.84K |
Citigroup | 1.39M | 0.00% | $1.07M |
Top Buyers
Holder | Shares | % Assets | Change |
---|---|---|---|
Citigroup | 1.39M | 0.00% | 1.39M |
Renaissance | 519.30K | 0.00% | 113.30K |
Susquehanna group, llp | 48.19K | - | 48.19K |
Velan capital investment management lp | 25.00K | 0.02% | 25.00K |
Northern trust | 47.56K | - | 13.82K |
Top Sellers
Holder | Shares | % Assets | Change |
---|---|---|---|
Logos global management lp | - | - | -2.50M |
Pfizer | 157.65K | 0.15% | -1.73M |
Orbimed advisors | - | - | -1.14M |
Tang capital management | - | - | -404.14K |
Morgan stanley | 1.00 | - | -402.26K |
New Positions
Holder | Shares | % Assets | Change | Value |
---|---|---|---|---|
Citigroup | 1.39M | 0.00% | 1.39M | $1.07M |
Susquehanna group, llp | 48.19K | - | 48.19K | $37.15K |
Velan capital investment management lp | 25.00K | 0.02% | 25.00K | $19.27K |
Royal bank of canada | 403.00 | - | 403.00 | $1.00K |
Sold Out
Holder | Change |
---|---|
Qube research | -48.00 |
Advisor group | -1.19K |
Wells fargo & company/mn | -2.16K |
Charles schwab investment management | -10.00K |
Harbourvest partners | -10.04K |
Institutional Ownership Trends
Date | Holdings | Change % | Shares | Change % | Ownership | Change % | Increased Position | Change % | Decreased Position | Change % |
---|---|---|---|---|---|---|---|---|---|---|
Jun 30, 2025 | 30 | -23.08% | 10,546,766 | -31.36% | 37 | 1.23% | 8 | -20.00% | 10 | 11.11% |
Mar 31, 2025 | 39 | -15.22% | 15,365,612 | -4.18% | 54 | 1.67% | 10 | -28.57% | 9 | -30.77% |
Dec 31, 2024 | 43 | -2.27% | 15,687,542 | -1.12% | 56 | 1.74% | 14 | 27.27% | 12 | 20.00% |
Sep 30, 2024 | 44 | -10.20% | 15,865,008 | -0.90% | 56 | 1.72% | 11 | -42.11% | 10 | 11.11% |
Jun 30, 2024 | 49 | 4.26% | 16,009,479 | -0.83% | 57 | 1.71% | 19 | 18.75% | 9 | -18.18% |
Top Mutual Funds Shareholders
Holder | Shares | % Holding | Change |
---|---|---|---|
Vanguard US Total Market Shares ETF | 613.83K | 2.19% | - |
Vanguard Total Stock Mkt Idx Inv | 50.06K | 1.87% | -1.09K |
Federated Hermes MDT Small Cap Growth IS | 315.18K | 1.12% | - |
Federated Hermes MDT SCG Institutional | 315.18K | 1.12% | - |
BlackRock Advantage Small Cap Core Instl | 169.79K | 0.61% | - |
Delaware Healthcare I | 150.00K | 0.54% | - |
Macquarie Healthcare I | 150.00K | 0.47% | - |
Vanguard Institutional Extnd Mkt Idx Tr | 11.56K | 0.43% | -5.27K |
Fidelity Extended Market Index | 123.41K | 0.38% | - |
LUNIS Biotech Growth Opp Fd I a | 64.07K | 0.23% | -17.50K |
Insider Transactions Trends
Date | Buy | Sell |
---|---|---|
2024 Q2 | - | - |
2024 Q1 | - | - |
2023 Q2 | - | - |
2023 Q1 | - | - |
2022 Q2 | - | - |
NXTC Ownership FAQ
Try Tickergate Pro Free
Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)
Customize your own personal stocks lists, views and charts
Choose from hundreds of fields, up to 15 years of history
Conduct deep comparison analysis
Discover trending investment themes
Find your next best investment
Research stocks using tools